Medicare Enrolled

Dr. Michael O'Brien, M.D.

Family Medicine · Poland, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
6615 CLINGAN ROAD, Poland, OH 44514
3307071425
In practice since 2005 (20 years)
NPI: 1386628170 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. O'Brien from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. O'Brien? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. O'Brien

Dr. Michael O'Brien is a family medicine specialist in Poland, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. O'Brien performed 2,199 Medicare services across 1,533 unique beneficiaries.

Between the years covered by Open Payments, Dr. O'Brien received a total of $13,475 from 71 pharmaceutical and/or device companies across 709 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. O'Brien is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 5% volume in OH $13,475 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,199
Medicare services
Top 5% in OH for family medicine
1,533
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~110 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
516 $8 $10
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
439 $51 $95
Annual alcohol misuse screening, 5 to 15 minutes 190 $16 $20
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
183 $74 $135
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
169 $116 $140
Annual depression screening 169 $16 $25
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
151 $2 $12
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
89 $8 $40
Influenza vaccine, quadrivalent, 0.5 ml dosage 55 $20 $25
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
55 $29 $35
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
47 $33 $120
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
40 $9 $30
Urine microalbumin test (kidney screening)
A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage.
26 $6 $35
Transitional care management, high complexity
Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem.
21 $198 $285
Annual wellness visit, initial visit
A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment.
21 $142 $175
Respiratory virus detection test
A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus and influenza viruses.
14 $32 $71
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
14 $36 $65
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,475
Total received (2018-2024)
Avg $1,925/year across 7 years
Top 3% in OH for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
709
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,049 (74.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,426 (25.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,591
2023
$1,530
2022
$1,843
2021
$1,824
2020
$1,313
2019
$1,273
2018
$1,100

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Smith+Nephew, Inc.
$3,362
AstraZeneca Pharmaceuticals LP
$349
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$153
Novo Nordisk Inc
$107
ABBVIE INC.
$85
Corcept Therapeutics
$66
Boehringer Ingelheim Pharmaceuticals, Inc.
$62
Exact Sciences Corporation
$48
PFIZER INC.
$47
IRONSHORE PHARMACEUTICALS INC.
$41
Amgen Inc.
$40
Lilly USA, LLC
$32
ACADIA Pharmaceuticals Inc
$22
Takeda Pharmaceuticals U.S.A., Inc.
$21
Esperion Therapeutics, Inc.
$21
Avion Pharmaceuticals
$20
Astellas Pharma US Inc
$19
Sumitomo Pharma America, Inc.
$18
SHIELD THERAPEUTICS INC
$18
Biogen, Inc.
$17
Janssen Pharmaceuticals, Inc
$17
Novartis Pharmaceuticals Corporation
$14
Acella Pharmaceuticals, LLC
$14
Top 3 companies account for 84.2% of 2024 payments
All-time payments by company (2018-2024) ›
Smith+Nephew, Inc.
$3,362
Amarin Pharma Inc.
$788
Amgen Inc.
$708
ABBVIE INC.
$657
AstraZeneca Pharmaceuticals LP
$649
Novo Nordisk Inc
$595
Merck Sharp & Dohme Corporation
$431
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$411
Teva Pharmaceuticals USA, Inc.
$407
Janssen Pharmaceuticals, Inc
$345
PFIZER INC.
$310
AbbVie Inc.
$303
Supernus Pharmaceuticals, Inc.
$262
Bayer HealthCare Pharmaceuticals Inc.
$257
Boehringer Ingelheim Pharmaceuticals, Inc.
$214
Corium, LLC
$214
Allergan, Inc.
$203
Merck Sharp & Dohme LLC
$191
Kowa Pharmaceuticals America, Inc.
$186
Biohaven Pharmaceutical Holding Company Ltd.
$186
Romark Laboratories, LC
$176
Novartis Pharmaceuticals Corporation
$160
Takeda Pharmaceuticals U.S.A., Inc.
$147
Astellas Pharma US Inc
$144
Regeneron Healthcare Solutions, Inc.
$139
Biohaven Pharmaceuticals, Inc.
$136
Lilly USA, LLC
$124
Esperion Therapeutics, Inc.
$117
Otsuka America Pharmaceutical, Inc.
$96
Abbott Laboratories
$95
Exact Sciences Corporation
$91
SANOFI-AVENTIS U.S. LLC
$75
Corcept Therapeutics
$66
Bayer Healthcare Pharmaceuticals Inc.
$61
Jazz Pharmaceuticals Inc.
$59
Clarus Therapeutics Inc.
$59
Genentech USA, Inc.
$59
Tris Pharma Inc
$56
Eisai Inc.
$52
NESTLE HEALTHCARE NUTRITION INC.
$48
Nestle HealthCare Nutrition Inc.
$47
Sumitomo Pharma America, Inc.
$46
Ironshore Pharmaceuticals Inc.
$46
Avanir Pharmaceuticals, Inc.
$45
JAZZ PHARMACEUTICALS INC.
$44
GlaxoSmithKline, LLC.
$43
IBSA Pharma Inc.
$43
IRONSHORE PHARMACEUTICALS INC.
$41
Bausch Health US, LLC
$37
Daiichi Sankyo Inc.
$37
Antares Pharma, Inc.
$33
Upsher-Smith Laboratories LLC
$30
Synergy Pharmaceuticals Inc
$30
Sunovion Pharmaceuticals Inc.
$27
Purdue Pharma L.P.
$25
ACADIA Pharmaceuticals Inc
$22
Avion Pharmaceuticals
$20
Shire North American Group Inc
$19
SHIELD THERAPEUTICS INC
$18
ITI, Inc.
$17
Biogen, Inc.
$17
Shield Therapeutics Inc
$17
Collegium Pharmaceutical, Inc.
$16
Amneal Pharmaceuticals LLC
$16
SANOFI PASTEUR INC.
$16
Neos Therapeutics, LP
$15
E.R. Squibb & Sons, L.L.C.
$15
Acella Pharmaceuticals, LLC
$14
Allergan Inc.
$12
Currax Pharmaceuticals LLC
$12
ARBOR PHARMACEUTICALS, INC.
$12
Top 3 companies account for 36.1% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ACCRUFER · AIRSUPRA · AJOVY · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Aimovig · AirDuo Digihaler · Alinia · Alinia Tablets 500mg 30 count bottle · Amitiza · Azstarys · BELSOMRA · BREZTRI · CAPLYTA · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · CREON · Cologuard Collection Kit · DIFICID · DUPIXENT · Dayvigo · Dyanavel XR · ELIQUIS · ELYXYB - celecoxib · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · FASENRA · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · FreeStyle Libre · GARDASIL 9 · GEMTESA · HEALICOIL · HUMIRA · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · JATENZO · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · Kerendia · Korlym · LANTUS · LEQVIO · LINZESS · LYRICA · Livalo · MENQUADFI · MIGRANAL · MOUNJARO · MYDAYIS · MYRBETRIQ · NEXLETOL · NOCDURNA · NP Thyroid 60 · NUEDEXTA · NUPLAZID · NURTEC ODT · OFEV · Otezla · Ozempic · PNEUMOVAX 23 · PREVNAR 20 · Prolia · QELBREE · QULIPTA · REXULTI · ROTATEQ · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SKYCLARYS · SOLIQUA 100/33 · STEGLATRO · STIOLTO RESPIMAT · SUNOSI · SYMPROIC · Saxenda · TOSYMRA SUMATRIPTAN NASAL SPRAY · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · Tirosint · Tresiba · Trintellix · Trulance · UBRELVY · UNITHROID · VERQUVO · VESICARE · VIBERZI · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Vyvanse · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xofluza · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (75%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for family medicine in OH.

Looking for a family medicine specialist in Poland?
Compare family medicine physicians in the Poland area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
349
Per 100K population
153.7
County median income
$55,576
Nearest hospital
HMHP ST ELIZABETH BOARDMAN HEALTH CENTER
3.7 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. O'Brien is a clinical cardiology specialist, with above-average Medicare volume (top 5% in OH), with low-engagement industry engagement in the top 3% of OH peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. O'Brien experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. O'Brien performed 516 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. O'Brien receive payments from pharmaceutical companies?
Yes. Dr. O'Brien received a total of $13,475 from 71 companies across 709 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. O'Brien's costs compare to other family medicine physicians in Poland?
Dr. O'Brien's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. O'Brien) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →